Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome

NCT02326051 is registered in ClinicalTrials.gov with Mohamed Sayed Abdelhafez as lead sponsor.

NCT NCT02326051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome
Lead sponsor
Mohamed Sayed Abdelhafez
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2014
Completion date
May 31, 2017
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, recurrent miscarriage